Tags |
|
|
Links |
|
|
Top Articles - Stop Losses
Stop losses, is one of the biggest challenge that makes a difference between a successful and unsuccessful trader.
It is a c
It is a c
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ommon factor many traders do not use stops and of those who say they use stops, hardly actually does it. Even more striking
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
is the number of stops that are moved or pulled off the board as a stock approaches them. It is very easy for a trader to sta
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
rt out by saying that he or she will use a ‘mental stop’, which usually is the same as no stop. And for many who start out wi
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
th a stop order in place, it is just as easy to ‘change your mind’ on a stock and cancel that stop. Because after all, to man
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
y it is hard to admit defeat, which is what many think having a stop hit is.
Let us try to think about it another way. When
Let us try to think about it another way. When
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
you leave a trade with a stop, it is not losing or giving up. It is also NOT cutting your losses. When you enter a trade you
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
do so with hope and an expectation. Herein lies the problem; you expect it to move in your favor and you hope to make money.
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
A move in your favor means you win and against you, you lose. WRONG!!!! Trading is not about wining and losing. Really? Yes r
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
eally. It is about doing the right thing at the right time. You cannot beat the market. The best you can do is profitably coe
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ist with the market. You have no control over the way the market moves so you cannot beat it. The best trading systems out th
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ere are not more than an educated guess and they all have disclaimers because they are inconsistent. So maybe part of the ans
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
wer for those who have a problem following through on this concept is to just call it a stop, not a stop loss.
When you have
When you have
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
a plan for a trade you wait until your triggers are hit, enter the trade and then let the stock do what it was going to do a
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
nyway. You simply react and trade when it meets your criteria to trade. Again, the trick to never being wrong is being willin
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
g to give up being right. It's not about right and wrong and you can in fact trade actively and confidently and profitably wi
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
th out forming an opinion.
The bottom line is that after you have decided to make a trade and set your stops, stop thinking
The bottom line is that after you have decided to make a trade and set your stops, stop thinking
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
about it! The stock is going to do what it is going to do. You have just set some parameters and made some educated projectio
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ns about its future course. From this point on, you are not right or wrong; you are just putting capital to work with a calcu
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
lated risk factor. Only when you master this concept will you be totally comfortable within the arena of shorter-term trading
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.toparticles.org.ua/article/102279/toparticles-Stop-Losses.html">Stop Losses</a>
BB link (for phorums):
[url=http://www.toparticles.org.ua/article/102279/toparticles-Stop-Losses.html]Stop Losses[/url]
Related Articles:
B2B Direct Mail Lists: Ask These Questions Before Renting
10 Easy Tips to Help You Make Money From Your Website
Excessive Credit Card Debt Solutions
Bookmark it:
|